AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Nuo Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026
- Market cap
- $60.99M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 17, 2026 | Before market open | $1.77M | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 14, 2026 | After market close | $1.30M | $-0.01 | – |
| Q3 FY2015 Ended Sep 30, 2015 | Nov 13, 2015 | After market close | – | – | – |
| Q2 FY2015 Ended Jun 30, 2015 | Aug 13, 2015 | After market close | – | – | – |
| Q1 FY2015 Ended Mar 31, 2015 | May 14, 2015 | Before market open | – | – | – |
| Q4 FY2014 Ended Dec 31, 2014 | Mar 31, 2015 | After market close | – | – | – |
| Q4 FY2012 Ended Dec 31, 2012 | Feb 20, 2013 | Before market open | – | – | – |
| Q2 FY2012 Ended Jun 30, 2012 | Jul 10, 2012 | After market close | – | – | – |
Press releases
Announcements Nuo Therapeutics filed with the SEC
8285 El Rio, Suite 190
Results of operations · EX-99 to Form 8-K
8285 El Rio, Suite 190
Results of operations · EX-99 to Form 8-K